Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.
about
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderCopy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative DiseasesGenome-wide copy number variation in sporadic amyotrophic lateral sclerosis in the Turkish population: deletion of EPHA3 is a possible protective factor.Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review.Genetics of low spinal muscular atrophy carrier frequency in sub-Saharan Africa.Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice.Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges.Linking amyotrophic lateral sclerosis and spinal muscular atrophy through RNA-transcriptome homeostasis: a genomics perspective.Copy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach.Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion.Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset.Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.
P2860
Q24626017-8E7580FF-C5BB-4119-935B-1FB3D47B6F74Q26750803-676BB0BF-1DAA-4B0C-93F1-DA734136D2DAQ31132884-DF60871F-1C0B-42C5-B21A-B1FAC27DFEE8Q33869164-466AD892-6319-4EF2-B63D-7A6E643C43B0Q33957888-40B29FB8-1095-41DB-A058-CFD6709F1D9AQ37572652-8FD9E809-C96F-44D6-ACE9-141E1B853786Q38260359-5A52DC39-6753-416C-80FC-EA7B5A2F2877Q39039061-60D57947-9157-48F8-A810-A8C103F79029Q39102149-27CB5026-BAEA-4B01-A27C-45C7EACECD40Q42100957-219E5814-97C0-4DF1-AF13-B810AAFA848AQ46454338-5DDA7E31-DB76-4728-9E7D-3BAAFA741442Q47152662-550CA8F9-A50E-423F-A463-6EBD26BBE242
P2860
Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.
@ast
Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.
@en
type
label
Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.
@ast
Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.
@en
prefLabel
Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.
@ast
Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.
@en
P2093
P2860
P50
P356
P1476
Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.
@en
P2093
Catherine Antar
Charlotte Veyrat-Durebex
Christian R Andres
Helene Blasco
Julien Praline
Patrick Vourc'h
Rayomand Press
William Camu
Yves-Olivier Guettard
P2860
P2888
P304
P356
10.1038/EJHG.2011.255
P577
2012-01-25T00:00:00Z
P5875
P6179
1013359425